Should radioimmunotherapy be an initial treatment option in advanced-stage follicular lymphoma? Commentary Journal Article
| Author: | Portlock, C. S. |
| Article Title: | Should radioimmunotherapy be an initial treatment option in advanced-stage follicular lymphoma? Commentary |
| Keywords: | overall survival; clinical trial; neutropenia; advanced cancer; ibritumomab tiuxetan; cancer staging; outcome assessment; blood toxicity; thrombocytopenia; myalgia; arthralgia; whole body radiation; short survey; flu like syndrome; headache; hypothyroidism; radioimmunotherapy; drug dose regimen; tositumomab i 131; follicular lymphoma; antibody; thyroid hormone; tositumomab; myelodysplasia |
| Journal Title: | Nature Clinical Practice Oncology |
| Volume: | 2 |
| Issue: | 7 |
| ISSN: | 1743-4254 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2005-07-01 |
| Start Page: | 346 |
| End Page: | 347 |
| Language: | English |
| DOI: | 10.1038/ncponc0227 |
| PROVIDER: | scopus |
| PUBMED: | 16075793 |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 24 October 2012" - "Source: Scopus" |
